Edition:
United States

Cellectar Biosciences Inc (CLRB.OQ)

CLRB.OQ on NASDAQ Stock Exchange Capital Market

1.11USD
25 Apr 2018
Change (% chg)

-- (--)
Prev Close
$1.11
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
36,402
52-wk High
$2.10
52-wk Low
$1.05

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 0.00 -0.322
Sep '17 0.00 -0.258
Jun '17 0.00 -0.232
Mar '17 0.00 -0.241
FY 2016 Dec '16 0.00 -0.344
Sep '16 0.00 -0.426
Jun '16 0.00 -0.493
Mar '16 0.00 0.910
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 1 0.00 0.00 0.00 0.00
Year Ending Dec-19 1 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Jun-18 1 -0.20 -0.20 -0.20 -0.22
Quarter Ending Sep-18 1 -0.15 -0.15 -0.15 -0.22
Year Ending Dec-18 1 -0.71 -0.71 -0.71 -0.85
Year Ending Dec-19 1 -0.61 -0.61 -0.61 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 29.67 32.21
P/E High - Last 5 Yrs. -- 40.42 45.93
P/E Low - Last 5 Yrs. -- 23.85 24.67
Beta 0.72 0.80 0.79
Price to Sales (TTM) -- 4.38 7.12
Price to Book (MRQ) 1.90 3.83 4.90
Price to Tangible Book (MRQ) 1.97 4.68 6.48
Price to Cash Flow (TTM) -- 21.56 24.70
% Owned Institutions 12.54 1.21 2.29

Dividends

  Company industry sector
Dividend Yield -- 1.68 1.57
Dividend Yield - 5 Year Avg -- 0.74 0.77
Dividend 5 Year Growth Rate -- 2.84 4.07
Payout Ratio(TTM) -- 20.60 20.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 7.29 9.38
Sales (TTM) vs TTM 1 Yr. Ago -- 10.11 11.18
Sales - 5 Yr. Growth Rate -- 7.66 8.21
EPS (MRQ) vs Qtr. 1 Yr. Ago 6.29 21.31 24.18
EPS (TTM) vs TTM 1 Yr. Ago -198.37 -- --
EPS - 5 Yr. Growth Rate -- 9.10 10.39
Capital Spending - 5 Yr. Growth Rate 28.83 9.71 10.42

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.52 2.53
Current Ratio (MRQ) 5.17 3.59 3.59
LT Debt to Equity (MRQ) 0.02 8.75 11.47
Total Debt to Equity (MRQ) 0.05 11.07 14.16
Interest Coverage (TTM) -- 36.00 30.45

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 54.93 54.23
Gross Margin - 5 Yr. Avg. -- 52.15 52.19
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.42 15.91
Operating Margin (TTM) -- 12.91 3.78
Operating Margin - 5 Yr. Avg. -- 14.19 11.22
Pre-Tax Margin (TTM) -- 13.17 4.45
Pre-Tax Margin - 5 Yr. Avg. -- 14.55 11.53
Net Profit Margin (TTM) -- 9.56 1.07
Net Profit Margin - 5 Yr. Avg. -- 10.87 7.86
Effective Tax Rate (TTM) -- 22.44 31.76
Effective Tax Rate - 5 Yr. Avg. -- 23.64 24.25

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 896,683,328 790,924,504
Net Income/Employee (TTM) -- 105,279,184 92,823,068
Receivable Turnover (TTM) -- 5.56 5.51
Inventory Turnover (TTM) -- 2.53 3.47
Asset Turnover (TTM) 0.00 0.90 0.88

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -96.20 10.83 10.41
Return on Assets - 5 Yr. Avg. -79.65 12.01 11.41
Return on Investment (TTM) -110.95 13.44 13.05
Return on Investment - 5 Yr. Avg. -123.05 15.54 14.78
Return on Equity (TTM) -133.89 15.16 14.90
Return on Equity - 5 Yr. Avg. -139.34 16.75 16.12
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 21.47 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cellectar Biosciences Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 12.54%
# of Holders: 24
Total Shares Held: 2,180,961
3 Mo. Net Change: 16,000
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 1
# Reduced Positions: 0
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.